1Bryan B B,Schnitt S J,Collins L C.Ductal carcinoma in situ with basal-like phenotype:a possible precursor toinvasive basallike breast cancer[J].Mod Pathol,2006,19(5):617-621.
2Rakha E A,E1-Sayed M E,Green A R.Prognostic marker in triplenegative breast cancer[J].Cancer,2007,109(1):25-32.
6Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[ J]. Nature ,2000,406 : 747 - 752.
7Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochenical and clinical characterization of the basal-like subtype of invasive breast carcinoma [ J ]. Clin Cancer Res, 2004,10 ( 16 ) :5367 - 5374.
8Bertucci F. How basal are triple-negative breast cancers? [ J]. Int J Cancer,2008,123 ( 1 ) : 936 - 240.
9Sasa M, Bando Y,Takahashi M, et al. Screening for basal marker expression is necessary for decision of therapeutic strategy tbr triple-negative breast cancer [ J ]. J Surg Oncol, 2008,97 ( 1 ) : 30-34.
8N. Saltana, Clobdan 2012: Estimated Cancer incidence Mortalityand prevalence Worldwide in 2012. Available from http://globocaniarc fv/pefault aspx[ Accessed en 31 August, 2014 ].
9Perou CM, Sorlie T, Eisen MB, el al. Molecular portraits of humanbreast tumours[ J]. Nature ,2000,406(6797) :747-752.
10Morris G J, Naidu S, Topham A K, et al. Differences in breastcarcinoma characteristics in newly diagnosed African - Americanand Caucasian patients[ J]. Cancer,2007 ,110(4) :876-884.
